Stock Updates

How has Mead Johnson Nutrition Company:(NYSE:MJN) performed recently?

Mead Johnson Nutrition Company (NYSE: MJN) is a large market cap stock with a market cap of 17083.58. It is in the Processed & Packaged Goods industry and sector Consumer Goods, with a current P/E of 34.61, a forward P/E of 24.01 and EPS of 2.64. At a stock price of 90.97 (-0.25%) it has a dividend yield of 1.81%.

EPS growth for the last five years have been 8.20%, more recently this last year it has grown by -7.80%. The next year growth is going to be about 8.36% and more long-term 8.85% after five years. EPS growth quarter over quarter is -62.00%. Sales growth for the past five years have been 5.30% and sales growth quarter over quarter is -12.10%.

For performance, Mead Johnson Nutrition Company the past week has seen a gain of 1.59%. For the last month performance for Mead Johnson Nutrition Company is 6.94%. While the last quarter is 8.78% and half year, 32.14%. Finally for the year, performance is 6.10%.

The 52-week high for Mead Johnson Nutrition Company, is at -1.13%, and for the 52-week low it comes to a value of 40.27%. The 20-day simple moving average is 6.29% and 14.75% for the 200-day simple moving average.

Volatility for the week is at 1.08%, and for the month it is 1.88%. Mead Johnson Nutrition Company, has a target price of 88.09.

In terms of debt, long term debt/equity is *TBA, and for total debt/equity Mead Johnson Nutrition Company has *TBA. The gross margin is 64.20%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 2.1 and the quick ratio is 1.7.

Insider ownership is at 0.20%, with instituitional ownership at 98.70%. Mead Johnson Nutrition Company has a payout ratio of *TBA. With the total shares outstanding coming to 187.32. The shares float is 186.17, with the float short at 6.44%, with short ratio coming to 8.43.

In terms of returns, the return on assets see Mead Johnson Nutrition Company, get *TBA, with its returns on investment at 30.60%. Return on equity is *TBA. So will the investors see the target price of 88.09, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment